Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sensus Healthcare
Boca Raton, Florida, United Statessensushealthcare.com ↗
- Ownership
- Public · SRTS
- Employees
- ~54
- Development stage
- Commercial
01
Overview
Sensus Healthcare’s FDA-cleared superficial radiation therapy devices (SRT) are commercially available and widely used for non-invasive treatment of non-melanoma skin cancers and keloids. Clinical studies support their efficacy as a non-surgical alternative, especially for patients unsuitable for surgery or seeking to avoid scarring. The company’s latest product, the SRT‑100 Vision™, adds image-guided capabilities to further improve precision and outcomes.
- Therapeutic areas
- OncologyDermatology
- Modalities
- DeviceSuperficial radiation therapy systemBrachytherapy device
- Industry
- Therapeutic Medical Devices
02
Financials
- Market cap
- $48.1M
- Total revenue
- $27.5M
- Enterprise value
- $33.2M
Beyond the preview
Go deeper on Sensus Healthcare.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sensus Healthcare.